相似文献
1
ADAR, the carcinogenesis mechanisms of ADAR and related clinical applications.
Ann Transl Med. 2019 Nov;7(22):686. doi: 10.21037/atm.2019.11.06.
2
Mechanisms and implications of ADAR-mediated RNA editing in cancer.
Cancer Lett. 2017 Dec 28;411:27-34. doi: 10.1016/j.canlet.2017.09.036. Epub 2017 Sep 30.
3
Structural perspectives on adenosine to inosine RNA editing by ADARs.
Mol Ther Nucleic Acids. 2024 Jul 19;35(3):102284. doi: 10.1016/j.omtn.2024.102284. eCollection 2024 Sep 10.
4
New Insights into the Biological Role of Mammalian ADARs; the RNA Editing Proteins.
Biomolecules. 2015 Sep 30;5(4):2338-62. doi: 10.3390/biom5042338.
5
In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic.
Drug Resist Updat. 2017 May;32:16-22. doi: 10.1016/j.drup.2017.09.001. Epub 2017 Oct 4.
6
Adenosine-to-inosine RNA editing and human disease.
Genome Med. 2013 Nov 29;5(11):105. doi: 10.1186/gm508. eCollection 2013.
7
Adenosine Deaminases That Act on RNA (ADARs).
Enzymes. 2017;41:215-268. doi: 10.1016/bs.enz.2017.03.006. Epub 2017 Apr 14.
8
RNA editing by mammalian ADARs.
Adv Genet. 2011;73:87-120. doi: 10.1016/B978-0-12-380860-8.00003-3.
9
Harnessing ADAR-Mediated Site-Specific RNA Editing in Immune-Related Disease: Prediction and Therapeutic Implications.
Int J Mol Sci. 2023 Dec 26;25(1):351. doi: 10.3390/ijms25010351.
10
Novel Engineered Programmable Systems for ADAR-Mediated RNA Editing.
Mol Ther Nucleic Acids. 2020 Mar 6;19:1065-1072. doi: 10.1016/j.omtn.2019.12.042. Epub 2020 Jan 15.
引用本文的文献
1
Deciphering the mechanistic roles of ADARs in cancer pathogenesis, tumor immune evasion, and drug resistance.
Front Immunol. 2025 Aug 7;16:1621585. doi: 10.3389/fimmu.2025.1621585. eCollection 2025.
2
Unraveling ADAR-Mediated Protein Recoding: A Proteogenomic Exploration in Model Organisms and Human Pathology.
Int J Mol Sci. 2025 Jul 16;26(14):6837. doi: 10.3390/ijms26146837.
3
Computer-Aided Discovery of Natural Compounds Targeting the ADAR2 dsRBD2-RNA Interface and Computational Modeling of Full-Length ADAR2 Protein Structure.
Int J Mol Sci. 2025 Apr 25;26(9):4075. doi: 10.3390/ijms26094075.
4
ADAR-Mediated A>I(G) RNA Editing in the Genotoxic Drug Response of Breast Cancer.
Int J Mol Sci. 2024 Jul 6;25(13):7424. doi: 10.3390/ijms25137424.
5
ADAR Family Proteins: A Structural Review.
Curr Issues Mol Biol. 2024 Apr 26;46(5):3919-3945. doi: 10.3390/cimb46050243.
6
In Silico Discovery of Potential Inhibitors Targeting the RNA Binding Loop of ADAR2 and 5-HT2CR from Traditional Chinese Natural Compounds.
Int J Mol Sci. 2023 Aug 9;24(16):12612. doi: 10.3390/ijms241612612.
7
Targeting purine metabolism in ovarian cancer.
J Ovarian Res. 2022 Aug 13;15(1):93. doi: 10.1186/s13048-022-01022-z.
8
ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations.
RNA. 2022 Oct;28(10):1281-1297. doi: 10.1261/rna.079266.122. Epub 2022 Jul 21.
9
Rapid Eye Movement Sleep Deprivation Combined With Fluoxetine Protects Against Depression-Induced Damage and Apoptosis in Rat Hippocampi A1 Adenosine Receptor.
Front Psychiatry. 2021 Jul 16;12:599399. doi: 10.3389/fpsyt.2021.599399. eCollection 2021.
10
RNA editing in mesothelioma: a look forward.
Open Biol. 2020 Oct;10(10):200112. doi: 10.1098/rsob.200112. Epub 2020 Oct 14.
本文引用的文献
1
Dynamic inosinome profiles reveal novel patient stratification and gender-specific differences in glioblastoma.
Genome Biol. 2019 Feb 13;20(1):33. doi: 10.1186/s13059-019-1647-x.
2
The Role of RNA Editing in Cancer Development and Metabolic Disorders.
Front Endocrinol (Lausanne). 2018 Dec 18;9:762. doi: 10.3389/fendo.2018.00762. eCollection 2018.
3
Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule libraries.
Nucleic Acids Res. 2019 Feb 28;47(4):e22. doi: 10.1093/nar/gky1228.
4
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells.
Nat Commun. 2018 Dec 21;9(1):5450. doi: 10.1038/s41467-018-07824-4.
5
ADAR RNA editing in innate immune response phasing, in circadian clocks and in sleep.
Biochim Biophys Acta Gene Regul Mech. 2019 Mar;1862(3):356-369. doi: 10.1016/j.bbagrm.2018.10.011. Epub 2018 Oct 31.
6
ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.
Biol Res. 2018 Oct 5;51(1):36. doi: 10.1186/s40659-018-0185-4.
7
RNA editing derived epitopes function as cancer antigens to elicit immune responses.
Nat Commun. 2018 Sep 25;9(1):3919. doi: 10.1038/s41467-018-06405-9.
8
A protein-protein interaction underlies the molecular basis for substrate recognition by an adenosine-to-inosine RNA-editing enzyme.
Nucleic Acids Res. 2018 Oct 12;46(18):9647-9659. doi: 10.1093/nar/gky800.
9
Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis.
Blood. 2018 Sep 20;132(12):1304-1317. doi: 10.1182/blood-2018-02-832576. Epub 2018 Jul 30.
10
Identification of RNA-binding protein targets with HyperTRIBE.
Nat Protoc. 2018 Aug;13(8):1829-1849. doi: 10.1038/s41596-018-0020-y.
Zotero 插件